CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
primary trial objective is to demonstrate that ODM-201 produces prostate-specific antigen (PSA) response rates at 24 weeks (defined as ≥80% ...
Phase 2
Valencia, Spain and 12 other locations
This is a Phase 1/2, open-label, randomized, dose finding and dose expansion study to evaluate the safety, preliminary efficacy, and PK of gedatolisi...
Phase 1, Phase 2
Valencia, Spain and 12 other locations
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer...
Phase 1, Phase 2
Valencia, Spain and 51 other locations
Metastatic prostate cancer is an incurable disease that typically spreads beyond the prostate. The standard of care is to ...
Phase 2, Phase 3
Valencia, Spain and 29 other locations
There are many treatment options for men with various stages of prostate cancer. Some treatments work well for a while but can caus ...
Phase 1
Valencia, Spain and 25 other locations
with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....
Phase 4
Valencia, Spain and 53 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Valencia, Spain and 345 other locations
docetaxel with or without local radiotherapy with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate...
Phase 3
Valencia, Spain and 76 other locations
as a single agent and in combination with standard-of-care androgen receptor pathway inhibitors (ARPIs) in adult patients with metastatic prostate...
Phase 1
Valencia, Spain and 12 other locations
This is a phase III, randomized, open-label, multi-center study to assess the efficacy of treatment intensification with docetaxel plus apalutamide a...
Phase 3
Valencia, Valencia, Spain and 55 other locations
Clinical trials
Research sites
Resources
Legal